Amplifica Completes $26 Million Series B Financing To Advance Injectable Pipeline For Hair Growth. The Round, Led By Tasso Partners, Will Support Clinical Development Of Innovative Therapies Aimed At Hair Loss. announced it raised $26 Million in an initial filing from an offering of $25 Million
PRIVATEAug 12, 2026
Amount Raised
$26 Million
Round Type
Series B
San DiegoBiotechnologyHealth CareFashionTherapeutics
Investors
Tasso Partners, LLCEli Lilly And CompanyScopia Capital Management, LP
Description
Amplifica Holdings Group, Inc. announced the closing of an oversubscribed $26 million Series B Preferred Stock financing. The round was led by Tasso Partners, with participation from Eli Lilly and other investors. Proceeds will be used to advance the clinical development of their novel pipeline candidates aimed at reactivating hair follicles
Company Information
Company
Amplifica Holdings Group
Location
San Diego, California, United States
About
Amplifica is a clinical-stage biopharmaceutical company focused on developing novel treatments to address androgenetic alopecia (hair loss), a condition estimated to affect over 50 million men and over 30 million women in the United States alone. The Company is taking a nature-inspired scientific approach using a molecular mechanism that regrows natural hair. Amplifica has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair. The Company is set to initiate product development programs and clinical trials to evaluate the safety and efficacy of its core technology.
Fundz sees it the moment Amplifica Holdings Group raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealth CareFashionTherapeutics